About AiCure
AiCure is a leading AI and advanced data analytics company specializing in clinical trial optimization through its flagship platform, H.Code. The company has pioneered AI-powered adherence verification technology trusted by pharmaceutical companies, contract research organizations (CROs), and healthcare providers to verify medication and clinical behavior adherence across the healthcare lifecycle. H.Code combines AI-powered computer vision, synchronous chat, and predictive analytics to remotely observe and assist trial participants through their smartphones, revolutionizing access and participation while improving statistical power and deepening understanding of the relationship between patient behavior and trial outcomes. The platform supports all types of clinical trials—traditional site-based, decentralized, fully virtual, or hybrid models—across any therapeutic indication. AiCure's technology has been deployed across more than 2,200 clinical trial sites in 46 countries, capturing over 1.5 million participant doses with a 92% participant retention rate. The company's research demonstrates that early medication adherence captured through H.Code can serve as a marker for participant retention, with their Clinical Site Services framework reducing early termination rates for adherent participants to just 7.8% across 28 phase I-IV clinical trials. AiCure serves seven of the top 10 global pharmaceutical companies and has been awarded 84 patents for its innovative approach to clinical trial patient engagement and adherence monitoring.
Mission & Story
Mission
Make the trial experience better, for everyone. H.Code is designed to be a bridge between your patients and your clinical team, making clinical trials more convenient and accessible for participants and more manageable and effective for clinical sites and study teams.
Clinical Focus
Medical conditions and clinical areas addressed by AiCure.
Who It Serves
Milestones & Awards
Recent Milestones
Over 2,200 clinical trial sites deployed, 1.5+ million participant doses captured, 84 patents awarded, research published on early termination prediction
Awards & Recognition
84 patents awarded for adherence verification and clinical trial technology
Key Partnerships
Social & Media
Latest Updates
Forbes: The AI Company Transforming Medication Adherence And Weight Loss
Today
AiCure Appoints Sabina Chadha as CEO, Ed Ikeguchi Transitions to Chief Medical Officer, and Josh Wilson Promoted to COO and President
1y ago
Clinical Research, Inequality and the Future of Women’s Health
1y ago
From Guidelines to Standards: Why Comprehensive AI Regulation is Essential to Spurring Innovation
2y ago
Putting the Patient at the Top of Your Adherence Approach
3y ago
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 42 →
Antidote
Antidote connects patients with clinical trials through precision recruitment services and their Match search engine. They help pharmaceutical sponsors accelerate enrollment while making it easier for patients to find relevant research opportunities.
BEKhealth
BEKhealth transforms structured and unstructured EHR data into clinical intelligence for trial recruitment and real-world evidence. The platform uses AI to match patients to complex trial criteria in minutes and generates longitudinal real-world data across 30M+ patients and 200+ research sites.
BenevolentAI
public · 180 employees
BenevolentAI unites AI and cutting-edge science to discover and develop new medicines, leveraging a knowledge graph and proprietary ontologies.
Biorce
Biorce develops Aika, an explainable AI platform that accelerates clinical trial design, feasibility assessment, and regulatory planning. The platform helps pharmaceutical companies and CROs reduce trial setup time by 90%, prevent costly protocol amendments, and bring treatments to patients faster.
BIOS Health
BIOS Health develops neural interfaces and AI platforms that read and write the body's neural data to understand and correct signals in real-time. The company enables neural digital therapies for chronic diseases through biomarker discovery and personalized dosing optimization.
Castor
Castor provides an integrated eClinical platform for clinical trials and research, offering EDC, eCOA/ePRO, eConsent, and DCT solutions. The company serves biopharma, CROs, medical device companies, and academic researchers across 100+ countries with over 2,500 commercial trials.
Circuit Clinical
Circuit Clinical is an Integrated Research Organization (IRO) that brings clinical trials directly into community healthcare settings. They partner with physicians, health systems, and FQHCs to expand access to clinical research in historically underrepresented communities across the United States.
Clario
Clario provides digital endpoint technology and evidence generation solutions for clinical trials. The company offers cardiac safety, eCOA, medical imaging, precision motion, and respiratory solutions to pharmaceutical, biotech, and CRO clients across all trial phases.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.